People on the Move
MedImmune II
Medimmune made a further hire this week with the appointment of Anand Subramony as VP, Drug Delivery and Device Development within Biopharmaceutical Development. The company said it was focusing on biologics delivery and device development.
Subramony’s past work has contributed to the understanding of transdermal delivery of small molecules, peptides and biologics. He joins MedImmune from the Novartis Institutes for Biomedical Research in Cambridge, Massachusetts, where he established the Novel Delivery Technologies and Therapeutics group.
He has also worked at Dr. Reddy’s Laboratories in New Jersey and Johnson & Johnson/Alza Corporation in California.
MedImmune’s owner, AstraZeneca, last week announced it was selling off a UK site, taking a $275m hit.